The Job Research Foundation has announced its ninth round of research funding to support scientists investigating the causes and potential treatments for Job Syndrome, a rare multisystem immunodeficiency disorder.
The Foundation will provide up to two research grants of $200,000 each over a two-year period to support scientific studies focused on understanding the disease and developing improved treatment options. Applications are open to researchers worldwide, with selected grant recipients expected to be announced in January 2027.
Since its establishment, the Job Research Foundation has funded 17 research projects globally as part of its mission to accelerate discoveries that could lead to better therapies and ultimately a cure for Job Syndrome.
The organization said its long-term goal is to advance research toward finding a cure, while its immediate focus is improving treatment options and quality of life for people currently living with the condition. Researchers who have previously applied are encouraged to submit new proposals and explore collaborations with other institutions to expand the impact of their work.
Also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), Job Syndrome is a rare immune disorder that affects people worldwide. The condition was first identified in 1966 and is associated with complex immune system challenges requiring continued scientific investigation.
The latest funding opportunity reflects the Foundation’s ongoing commitment to supporting innovative research and creating new opportunities for scientists working to better understand rare diseases and develop effective treatments.
